₹ 471.65
7.55 (1.63%)
C
Cohance Lifesciences
₹ 471.65
COHANCE Financials Summary (Consolidated)
Cohance Lifesciences revenue increased 12.57% quarter-on-quarter to ₹489 Cr in Sep 2026, while net profit turned positive at ₹2 Cr from a loss of ₹45 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 14.37% and net profit is down 96.54%. EPS for the quarter stood at ₹0.40, increased from -₹0.63 in the previous quarter and down from ₹1.94 a year ago.
Cohance Lifesciences Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of COHANCE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
COHANCE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






